Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypersensitivity Reaction

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 29 articles:
HTML format
Text format



Single Articles


    February 2018
  1. THE LANCET
    Asthma in US children.
    Lancet. 2018;391:632.
    PubMed     Text format    


    January 2018
  2. MOSLER G, Euba T
    Taking control through drama.
    Lancet. 2018;391:303-304.
    PubMed     Text format    


  3. WATTS G
    Ian Pavord: engaging with the eosinophil.
    Lancet. 2018;391:301.
    PubMed     Text format    


  4. CROOKS MG, Faruqi S, Morice AH
    How does azithromycin improve asthma exacerbations?
    Lancet. 2018;391:28.
    PubMed     Text format    


  5. GIBSON PG
    How does azithromycin improve asthma exacerbations? - Author's reply.
    Lancet. 2018;391:28-29.
    PubMed     Text format    


    October 2017
  6. AERTS O, Herman A, Bruze M, Goossens A, et al
    FreeStyle Libre: contact irritation versus contact allergy.
    Lancet. 2017;390:1644.
    PubMed     Text format    


    September 2017
  7. KLEINERT S, Horton R
    After asthma: airways diseases need a new name and a revolution.
    Lancet. 2017 Sep 11. pii: S0140-6736(17)32205.
    PubMed     Text format    


  8. PAVORD ID, Beasley R, Agusti A, Anderson GP, et al
    After asthma: redefining airways diseases.
    Lancet. 2017 Sep 11. pii: S0140-6736(17)30879.
    PubMed     Text format    


    July 2017
  9. BRUSSELLE G, Pavord I
    Azithromycin in uncontrolled asthma.
    Lancet. 2017 Jul 4. pii: S0140-6736(17)31547.
    PubMed     Text format    


    May 2017
  10. STROWD LC, Feldman SR
    Dupilumab for atopic dermatitis.
    Lancet. 2017 May 4. pii: S0140-6736(17)31192.
    PubMed     Text format    


  11. BLAUVELT A, de Bruin-Weller M, Gooderham M, Cather JC, et al
    Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Lancet. 2017 May 4. pii: S0140-6736(17)31191.
    PubMed     Text format     Abstract available


    March 2017
  12. FITZGERALD JM, Emery P
    Modifying the trajectory of asthma-are there lessons from the use of biologics in rheumatology?
    Lancet. 2017;389:1082-1084.
    PubMed     Text format    


    December 2016
  13. THE LANCET
    Building the evidence base for safety in food allergy.
    Lancet. 2016;388:2838.
    PubMed     Text format    


  14. ROBERTS G
    Another step towards prevention of food allergy.
    Lancet. 2016 Dec 7. pii: S0140-6736(16)31661.
    PubMed     Text format    


  15. NATSUME O, Kabashima S, Nakazato J, Yamamoto-Hanada K, et al
    Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Dec 7. pii: S0140-6736(16)31418.
    PubMed     Text format     Abstract available


  16. WENZEL SE, Jayawardena S, Graham NM, Pirozzi G, et al
    Severe asthma and asthma-chronic obstructive pulmonary disease syndrome - Authors' reply.
    Lancet. 2016;388:2742.
    PubMed     Text format    


  17. XIA Y, Cao C, Li W, Shen H, et al
    Severe asthma and asthma-chronic obstructive pulmonary disease syndrome.
    Lancet. 2016;388:2741-2742.
    PubMed     Text format    


    November 2016
  18. PAPI A, Fabbri LM
    Management of patients with early mild asthma and infrequent symptoms.
    Lancet. 2016 Nov 29. pii: S0140-6736(16)32111.
    PubMed     Text format    


  19. REDDEL HK, Busse WW, Pedersen S, Tan WC, et al
    Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study.
    Lancet. 2016 Nov 29. pii: S0140-6736(16)31399.
    PubMed     Text format     Abstract available


    October 2016
  20. GUAN WJ, Zheng XY, Chung KF, Zhong NS, et al
    Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action.
    Lancet. 2016;388:1939-1951.
    PubMed     Text format     Abstract available


  21. ZINK A, Bohner A, Schuch A, Biedermann T, et al
    Systemic mastocytosis with generalised skin involvement.
    Lancet. 2016 Oct 13. pii: S0140-6736(16)31710.
    PubMed     Text format    


    September 2016
  22. RUBIN R
    EpiPen price hike comes under scrutiny.
    Lancet. 2016;388:1266.
    PubMed     Text format    


  23. FITZGERALD JM, Bleecker ER, Nair P, Korn S, et al
    Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
    Lancet. 2016 Sep 5. pii: S0140-6736(16)31322.
    PubMed     Text format     Abstract available


  24. CASTRO M, Bacharier LB
    Treatment for severe eosinophilic asthma-consistent effect of anti-interleukin-5 antibodies?
    Lancet. 2016 Sep 2. pii: S0140-6736(16)31537.
    PubMed     Text format    


  25. BLEECKER ER, FitzGerald JM, Chanez P, Papi A, et al
    Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.
    Lancet. 2016 Sep 2. pii: S0140-6736(16)31324.
    PubMed     Text format     Abstract available


    June 2016
  26. WATTS G
    Robert Charles Strunk.
    Lancet. 2016;387:2500.
    PubMed     Text format    


  27. DEBAUN MR, Strunk RC
    The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.
    Lancet. 2016;387:2545-53.
    PubMed     Text format     Abstract available


    April 2016
  28. WENZEL S, Castro M, Corren J, Maspero J, et al
    Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Lancet. 2016 Apr 26. pii: S0140-6736(16)30307.
    PubMed     Text format     Abstract available


  29. CHUNG KF
    Dupilumab: a potential new treatment for severe asthma.
    Lancet. 2016 Apr 26. pii: S0140-6736(16)30311.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: